HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two bombesin analogues discriminate between neuromedin B- and bombesin-induced calcium flux in a lung cancer cell line.

Abstract
We examined the profile of two bombesin (BN) antagonists, (CH3)2CHCO-His-Trp-Ala-Val-D-Ala-His-Leu-NHCH3] (ICI 216140) and [D-Phe6,des-Met14]BN(6-14)ethylamide (DPDM-BN EA), against neuromedin B-induced Ca2+ mobilization in the small cell lung cancer (SCLC) line NCI-H345. Neuromedin B (NMB), a BN-like peptide sharing sequence homology with ranatensin, elicited a concentration-dependent Ca2+ release (in part) from intracellular stores. Sequential addition of NMB attenuated Ca2+ mobilization. Desensitization occurred between BN and NMB; depletion of intracellular Ca2+ is a likely mechanism because thapsigargin stimulated Ca2+ release after a maximally desensitizing dose of NMB. ICI 216140 and DPDM-BN EA competitively inhibited BN-induced Ca2+ transients. In contrast, these compounds antagonized NMB-stimulated Ca2+ transients in a noncompetitive manner. The pharmacological profiles obtained support receptor heterogeneity for BN-like peptides on this SCLC line, underscoring the need for thorough examination of dose-response relationships when investigating effects of BN analogues on intact cells.
AuthorsR R Ryan, J L Daniel, A Cowan
JournalPeptides (Peptides) 1993 Nov-Dec Vol. 14 Issue 6 Pg. 1231-5 ISSN: 0196-9781 [Print] United States
PMID8134305 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Oligopeptides
  • Peptide Fragments
  • bombesin (6-14)-ethylamide, Phe(6)-des-Met(14)-
  • ICI 216140
  • Neurokinin B
  • neuromedin B
  • Bombesin
  • Calcium
Topics
  • Amino Acid Sequence
  • Bombesin (analogs & derivatives, antagonists & inhibitors, pharmacology, physiology)
  • Calcium (metabolism)
  • Carcinoma, Small Cell (metabolism)
  • Humans
  • Lung Neoplasms (metabolism)
  • Molecular Sequence Data
  • Neurokinin B (analogs & derivatives, antagonists & inhibitors, physiology)
  • Oligopeptides (pharmacology)
  • Peptide Fragments (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: